January 4 Investor Conf. transcript well worth a read. | MNKD Message Board Posts

MannKind Corporation

  MNKD website

MNKD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  16330 of 16516  at  1/10/2019 8:30:40 AM  by

astrojny


January 4 Investor Conf. transcript well worth a read.

https://seekingalpha.com/article/4231518-mannkind-corporation-mnkd-ceo-michael-castagna-hosts-investor-conference-call-transcript?part=single 

An example:

"We are moving our own compounds forward throughout 2019. Tret T and recent and further STAT study results have validated our belief that Technosphere technology is a highly differentiated, innovative and unique delivery platform. We anticipate moving the following types of molecules forward.

Number one, a triptan for acute migraine, number two, a 5HT3 inhibitor for chemotherapy-induced nausea and vomiting. Number three, inhaled tobramycin for cystic fibrosis, and the fourth one is an undisclosed compound targeting a large consumer driven market that we are keeping confidential for competitive reasons."



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 137
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...